Quantitative Analysis of Innate Lymphoid Cells in Patients with ST-Segment Elevation Myocardial Infarction

References

• Akbar, H., Foth, C., & Kahloon, R. A. (2021). Acute ST elevation myocardial infarction. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK532281/
   Google Scholar
• Andreadou, I., Cabrera-Fuentes, H. A., Devaux, Y., Frangogiannis, N. G., Frantz, S., Guzik, T., Liehn, E. A., Gomes, C. P. C., Schulz, R., & Hausenloy, D. J. (2019, June 1). Immune cells as targets for cardioprotection: New players and novel therapeutic opportunities. Cardiovascular research, 115(7), 1117–1130.37. https://doi.org/10.1093/cvr/cvz050
   PubMed Web of Science ®Google Scholar
• Bénézech, C., & Jackson-Jones, L. H. (2019). ILC2 orchestration of local immune function in adipose tissue. Frontiers in Immunology, 10, 171. https://doi.org/10.3389/fimmu.2019.00171
   PubMed Web of Science ®Google Scholar
• Bracamonte-Baran, W., Chen, G., Hou, X., Talor, M. V., Choi, H. S., Davogustto, G., Taegtmeyer, H., Sung, J., Hackam, D. J., Nauen, D., & Čiháková, D. (2019). Non-cytotoxic cardiac innate lymphoid cells are a resident and quiescent type 2-commited population. Frontiers in Immunology, 10, 634. https://doi.org/10.3389/fimmu.2019.00634
   PubMed Web of Science ®Google Scholar
• Collet, J. P., Thiele, H., Barbato, E., Barthélémy, O., Bauersachs, J., Bhatt, D. L., Dendale, P., Dorobantu, M., Edvardsen, T., Folliguet, T., Gale, C. P., Gilard, M., Jobs, A., Jüni, P., Lambrinou, E., Lewis, B. S., Mehilli, J., Meliga, E., & Sibbing, D. (2021). 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal, 42(14), 1289–1367. https://doi.org/10.1093/eurheartj/ehaa575
   PubMed Web of Science ®Google Scholar
• Colonna, M. (2018). Innate lymphoid cells: Diversity, plasticity, and unique functions in immunity. Immunity, 48(6), 1104–1117. https://doi.org/10.1016/j.immuni.2018.05.013
   PubMed Web of Science ®Google Scholar
• Diefenbach, A. (2013). Innate lymphoid cells in the defense against infections. European Journal of Microbiology & Immunology, 3(3), 143–51. https://doi.org/10.1556/EuJMI.3.2013.3.1
   PubMedGoogle Scholar
• Diefenbach, A., Colonna, M., & Koyasu, S. (2014). Development, differentiation, and diversity of innate lymphoid cells. Immunity, 41(3), 354–365. https://doi.org/10.1016/j.immuni.2014.09.005
   PubMed Web of Science ®Google Scholar
• Ebbo, M., Crinier, A., Vély, F., & Vivier, E. (2017). Innate lymphoid cells: Major players in inflammatory diseases. Nature Reviews Immunology, 17(11), 665–678. https://doi.org/10.1038/nri.2017.86
   PubMed Web of Science ®Google Scholar
• Engelbertsen, D., & Lichtman, A. H. (2017). Innate lymphoid cells in atherosclerosis. European Journal of Pharmacology, 816, 32–36. https://doi.org/10.1016/j.ejphar.2017.04.030
   PubMed Web of Science ®Google Scholar
• Huang, S., & Frangogiannis, N. G. (2018, May). Anti-inflammatory therapies in myocardial infarction: Failures, hopes and challenges. British Journal of Pharmacology, 175(9), 1377–1400. https://doi.org/10.1111/bph.14155
   PubMed Web of Science ®Google Scholar
• Jaén, R. I., Val-Blasco, A., Prieto, P., Gil-Fernández, M., Smani, T., López-Sendón, J. L., Delgado, C., Boscá, L., & Fernández-Velasco, M. (2020, July 27). Innate immune receptors, key actors in cardiovascular diseases. JACC: Basic to Translational Science, 5(7), 735–749. https://doi.org/10.1016/j.jacbts.2020.03.015
   PubMedGoogle Scholar
• Kim, J., Ryu, S., & Kim, H. Y. (2021, May 31). Innate lymphoid cells in tissue homeostasis and disease pathogenesis. Molecules and Cells, 44(5), 301–309. https://doi.org/10.14348/molcells.2021.0053
   PubMed Web of Science ®Google Scholar
• Klose, C. S. N., Flach, M., Möhle, L., Rogell, L., Hoyler, T., Ebert, K., Fabiunke, C., Pfeifer, D., Sexl, V., Fonseca-Pereira, D., Domingues, R., Veiga-Fernandes, H., Arnold, S., Busslinger, M., Dunay, I., Tanriver, Y., & Diefenbach, A. (2014). Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell, 157(2), 340–356. https://doi.org/10.1016/j.cell.2014.03.030
   PubMed Web of Science ®Google Scholar
• Koprivica, I., Stanisavljević, S., Mićanović, D., Jevtić, B., Stojanović, I., & Miljković, Đ. (2023, October 17). ILC3: A case of conflicted identity. Frontiers in Immunology, 14, 1271699. https://doi.org/10.3389/fimmu.2023.1271699
   PubMed Web of Science ®Google Scholar
• Kumrić, M., Tičinović Kurir, T., Borovac, J. A., & Božić, J. (2020). The role of natural killer (NK) cells in acute coronary syndrome: A comprehensive review. Biomolecules, 10(11), 1514. https://doi.org/10.3390/biom10111514
   PubMed Web of Science ®Google Scholar
• Lai, S. L., Marín-Juez, R., & Stainier, D. Y. R. (2019). Immune responses in cardiac repair and regeneration: A comparative point of view. Cellular and Molecular Life Sciences : CMLS, 76(7), 1365–1380. https://doi.org/10.1007/s00018-018-2995-5
   PubMed Web of Science ®Google Scholar
• Leor, J., Rozen, L., Zuloff-Shani, A., Feinberg, M. S., Amsalem, Y., Barbash, I. M., Kachel, E., Holbova, R., Mardor, Y., Daniels, D., Ocherashvilli, A., Orenstein, A., & Danon, D. (2006). Ex vivo activated human macrophages improve healing, remodeling, and function of the infarcted heart. Circulation, 114(1 Suppl), I94–100. https://doi.org/10.1161/CIRCULATIONAHA.105.000331
   PubMedGoogle Scholar
• Li, J., Wu, J., Zhang, M., & Zheng, Y. (2020). Dynamic changes of innate lymphoid cells in acute ST-segment elevation myocardial infarction and its association with clinical outcomes. Scientific Reports, 10(1), 5099. https://doi.org/10.1038/s41598-020-61903-5
   PubMedGoogle Scholar
• Macfarlane, P. W., Browne, D., Devine, B., Clark, E., Miller, E., Seyal, J., & Hampton, D. (2004). Modification of ACC/ESC criteria for acute myocardial infarction. Journal of Electrocardiology, 37, 98–103. https://doi.org/10.1016/j.jelectrocard.2004.08.032
   PubMed Web of Science ®Google Scholar
• Mehta, S. R., Granger, C. B., Boden, W. E., Steg, P. G., Bassand, J.-P., Faxon, D. P., Afzal, R., Chrolavicius, S., Jolly, S. S., Widimsky, P., Avezum, A., Rupprecht, H.-J., Zhu, J., Col, J., Natarajan, M. K., Horsman, C., Fox, K. A. A., & Yusuf, S. (2009). Early versus delayed invasive intervention in acute coronary syndromes. The New England Journal of Medicine, 360(21), 2165–2175. https://doi.org/10.1056/NEJMoa0807986
   PubMed Web of Science ®Google Scholar
• Messing, M., Jan-Abu, S. C., & McNagny, K. (2020). Group 2 innate lymphoid cells: Central players in a recurring theme of repair and regeneration. International Journal of Molecular Sciences, 21(4), 1350. https://doi.org/10.3390/ijms21041350
   PubMed Web of Science ®Google Scholar
• Michel, T., Poli, A., Cuapio, A., Briquemont, B., Iserentant, G., Ollert, M., & Zimmer, J. (2016). Human CD56bright NK cells: An update. The Journal of Immunology, 196(7), 2923–2931. https://doi.org/10.4049/jimmunol.1502570
   PubMed Web of Science ®Google Scholar
• Mitchell, C., Rahko, P. S., Blauwet, L. A., Canaday, B., Finstuen, J. A., Foster, M. C., Horton, K., Ogunyankin, K. O., Palma, R. A., & Velazquez, E. J. (2019, January). Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: Recommendations from the American society of echocardiography. Journal of the American Society of Echocardiography, 32(1), 1–64. https://doi.org/10.1016/j.echo.2018.06.004
   PubMed Web of Science ®Google Scholar
• Murphy, J. M., Ngai, L., Mortha, A., & Crome, S. Q. (2022, March 10). Tissue-dependent adaptations and functions of innate lymphoid cells. Frontiers in Immunology, 13, 836999. https://doi.org/10.3389/fimmu.2022.836999
   PubMed Web of Science ®Google Scholar
• Newland, S. A., Mohanta, S., Clément, M., Taleb, S., Walker, J. A., Nus, M., Sage, A. P., Yin, C., Hu, D., Kitt, L. L., Finigan, A. J., Rodewald, H.-R., Binder, C. J., McKenzie, A. N. J., Habenicht, A. J., & Mallat, Z. (2017). Type-2 innate lymphoid cells control the development of atherosclerosis in mice. Nature Communications, 8(1), 15781. https://doi.org/10.1038/ncomms15781
   PubMedGoogle Scholar
• Oliphant, C. J., Hwang, Y., Walker, J., Salimi, M., Wong, S., Brewer, J., Englezakis, A., Barlow, J., Hams, E., Scanlon, S., Ogg, G., Fallon, P., & McKenzie, A. J. (2014). MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity, 41(2), 283–295. https://doi.org/10.1016/j.immuni.2014.06.016
   PubMed Web of Science ®Google Scholar
• Ortega-Rodríguez, A. C., Marín-Jáuregui, L. S., Martínez-Shio, E., Hernández Castro, B., González-Amaro, R., Escobedo-Uribe, C. D., & MonsiváMonsiváIs-Urenda, A. E. (2020). Altered NK cell receptor repertoire and function of natural killer cells in patients with acute myocardial infarction: A three-month follow-up study. Immunobiology, 225(3), 151909. https://doi.org/10.1016/j.imbio.2020.151909
   PubMed Web of Science ®Google Scholar
• Reed, G. W., Rossi, J. E., & Cannon, C. P. (2017). Acute myocardial infarction. The Lancet, 389(10065), 197–210. https://doi.org/10.1016/S0140-6736(16)30677-8
   PubMed Web of Science ®Google Scholar
• Roberts, L. B., Lord, G. M., & Howard, J. K. (2022, May 11). Heartbreakers or healers? Innate lymphoid cells in cardiovascular disease and obesity. Frontiers in Immunology, 13, 903678. https://doi.org/10.3389/fimmu.2022.903678
   PubMed Web of Science ®Google Scholar
• Spits, H., & DiSanto, J. P. (2011). The expanding family of innate lymphoid cells: Regulators and effectors of immunity and tissue remodeling. Nature Immunology, 12(1), 21–7. https://doi.org/10.1038/ni.1962
   PubMed Web of Science ®Google Scholar
• Spits, H., & Mjösberg, J. (2022, November). Heterogeneity of type 2 innate lymphoid cells. Nature Reviews Immunology, 22(11), 701–712. https://doi.org/10.1038/s41577-022-00704-5
   PubMed Web of Science ®Google Scholar
• Vivier, E., Artis, D., Colonna, M., Diefenbach, A., DiSanto, J. P., Eberl, G., Koyasu, S., Locksley, R. M., McKenzie, A. N. J., Mebius, R. E., Powrie, F., & Spits, H. (2018). Innate lymphoid cells: 10 years on. Cell, 174(5), 1054–1066. https://doi.org/10.1016/j.cell.2018.07.017
   PubMed Web of Science ®Google Scholar
• Wallrapp, A., Riesenfeld, S. J., Burkett, P. R., & Kuchroo, V. K. (2018). Type 2 innate lymphoid cells in the induction and resolution of tissue inflammation. Immunological Reviews, 286(1), 53–73. https://doi.org/10.1111/imr.12702
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2021). Cardiovascular diseases (CVDs) facts sheets. Retrieved August 23, 2022, from https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
   Google Scholar
• Xu, J. Y., Xiong, Y. Y., Tang, R. J., Jiang, W. Y., Ning, Y., Gong, Z. T., Huang, P. S., Chen, G. H., Xu, J., Wu, C. X., Hu, M. J., Xu, J., Xu, Y., Huang, C. R., Jin, C., Lu, X. T., Qian, H. Y., Li, X. D., & Yang, Y. J. (2022, July 20). Interleukin-5-induced eosinophil population improves cardiac function after myocardial infarction. Cardiovascular Research, 118(9), 2165–2178. https://doi.org/10.1093/cvr/cvab237
   PubMed Web of Science ®Google Scholar
• Yang, W., Lin, J., Zhou, J., Zheng, Y., Jiang, S., He, S., & Li, D. (2021, November 11). Innate lymphoid cells and myocardial infarction. Frontiers in Immunology, 12, 758272. https://doi.org/10.3389/fimmu.2021.758272
   PubMedGoogle Scholar